--- title: "Welldoc® 荣获 2026 年人工智能卓越奖" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/280660368.md" description: "Welldoc® 荣获商业智能集团颁发的 2026 年人工智能卓越奖，这是其在健康产品类别中连续第三次获奖。这一认可突显了 Welldoc 在医疗保健领域的人工智能领导地位，该技术结合了临床精确性和受监管的能力，为个人和医疗机构提供个性化的洞察。该公司旨在通过创新的、基于证据的支持项目来改善健康结果，并被认可为 CMS 健康科技生态系统倡议的早期采用者" datetime: "2026-03-26T15:50:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280660368.md) - [en](https://longbridge.com/en/news/280660368.md) - [zh-HK](https://longbridge.com/zh-HK/news/280660368.md) --- # Welldoc® 荣获 2026 年人工智能卓越奖 **Welldoc® Honored with 2026 Artificial Intelligence Excellence Award** _Third Win Reinforces Welldoc’s Leadership in Healthcare-Ready AI_ Welldoc®, an AI-powered health tech leader, today announced it has been named a winner in the 2026 Artificial Intelligence Excellence Awards presented by the Business Intelligence Group (BIG). The awards recognize organizations worldwide setting the standard for responsible AI with measurable, real-world impact. Welldoc was honored in the Health Product category for a third year. By combining clinical precision with regulated AI capabilities, Welldoc delivers the personalized insights necessary to empower individuals, care teams and healthcare organizations in navigating complex conditions. "We are honored to be recognized for our healthcare-ready AI, which defines the standard for responsible, outcomes-driven intelligence," said Anand Iyer, Chief AI Officer at Welldoc. "Our recognition as a CMS Health Tech Ecosystem early adopter further validates our commitment to establishing national benchmarks for secure, personalized interventions that move the needle on health outcomes." Welldoc is reimagining the "front door" of healthcare through a proprietary intelligence layer that creates a seamless experience across the entire health journey. By delivering clinically precise guidance, Welldoc enables its partners to launch differentiated, evidence-based support programs within highly regulated environments. "The AI industry is evolving at an incredible pace, and it is through the vision of companies like Welldoc that we see the true power of real-world applications," said Russ Fordyce, CEO of the Business Intelligence Group. "Welldoc’s work exemplifies the type of technical innovation and leadership that is essential to shaping a more efficient and intelligent future." **About Welldoc** Welldoc® is an AI-powered health technology leader committed to connecting people to better, more personalized cardiometabolic care. The company's digital health platform delivers a unified experience for individuals managing diabetes, obesity (including GLP-1 support), hypertension, heart failure, and complex comorbidities including diabetes in pregnancy, sleep apnea, chronic kidney disease (CKD), and metabolic dysfunction-associated steatohepatitis (MASH). The foundation of Welldoc's solution is healthcare-ready AI, a purpose-built engine grounded in unmatched clinical rigor, with 11 FDA clearances, 60 patents, and more than 100 peer-reviewed publications demonstrating clinical effectiveness and safety. The platform's architecture allows individuals to connect to over 400 devices and data sources, while also integrating seamlessly with electronic health record (EHR) systems, to enable comprehensive data interoperability across care settings. Welldoc partners across multiple healthcare sectors—including life sciences companies, health plans, health systems, and employers—to drive innovative health programs, improved patient outcomes, and reduced costs at scale. The company has been recognized as a leader in healthcare innovation, named one of TIME and Statista's World's Top HealthTech Companies and awarded "Best Overall Digital Health Company" by MedTech Breakthrough™ for multiple consecutive years. Welldoc is strategically aligned with federal modernization efforts, including being named an early adopter in the CMS 2025 Health Tech Ecosystem Initiative. This ensures the company’s AI-powered solutions support critical programs like the CMS Rural Health Transformation Program (RHTP) focused on rural healthcare access. For more information, visit www.welldoc.com. Follow us on LinkedIn and X. **About Business Intelligence Group** The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization's proprietary and unique scoring system selectively measures performance across multiple business domains and rewards those companies whose achievements stand above those of their peers. Visit www.bintelligence.com. Sylvia Aranda Real Chemistry Media@welldocinc.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260326901036/en/ ### 相关股票 - [FDHT.US](https://longbridge.com/zh-CN/quote/FDHT.US.md) - [TDOC.US](https://longbridge.com/zh-CN/quote/TDOC.US.md) - [EDOC.US](https://longbridge.com/zh-CN/quote/EDOC.US.md) - [HEAL.US](https://longbridge.com/zh-CN/quote/HEAL.US.md) ## 相关资讯与研究 - [英国大型企业普遍不清楚自身数据在海外被人工智能如何使用](https://longbridge.com/zh-CN/news/284177276.md) - [关于举办 “人工智能赋能科研实践效能提升与智能体构建应用” 高级研修班的通知](https://longbridge.com/zh-CN/news/284701000.md) - [人工智能产业日报 (04.28) : AI 产业动态](https://longbridge.com/zh-CN/news/284439874.md) - [北京市人工智能产业基金等入股新石器 后者增资至约 5017 万](https://longbridge.com/zh-CN/news/284166686.md) - [韩国今年将为 AI 工厂项目提供 530 亿韩元支持](https://longbridge.com/zh-CN/news/284503263.md)